vs
ICU MEDICAL INC（ICUI）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
RANGE RESOURCES CORP的季度营收约是ICU MEDICAL INC的1.5倍（$786.9M vs $540.7M），RANGE RESOURCES CORP净利率更高（22.8% vs -2.9%，领先25.7%），RANGE RESOURCES CORP同比增速更快（18.0% vs -14.1%），过去两年RANGE RESOURCES CORP的营收复合增速更高（14.6% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
ICUI vs RRC — 直观对比
营收规模更大
RRC
是对方的1.5倍
$540.7M
营收增速更快
RRC
高出32.1%
-14.1%
净利率更高
RRC
高出25.7%
-2.9%
两年增速更快
RRC
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $786.9M |
| 净利润 | $-15.7M | $179.1M |
| 毛利率 | 37.5% | 94.5% |
| 营业利润率 | 1.0% | — |
| 净利率 | -2.9% | 22.8% |
| 营收同比 | -14.1% | 18.0% |
| 净利润同比 | 34.0% | 88.8% |
| 每股收益（稀释后） | $-0.63 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUIRRC
| Q4 25 | $540.7M | $786.9M | ||
| Q3 25 | $537.0M | $655.3M | ||
| Q2 25 | $548.9M | $699.6M | ||
| Q1 25 | $604.7M | $846.3M | ||
| Q4 24 | $629.8M | $667.0M | ||
| Q3 24 | $589.1M | $567.9M | ||
| Q2 24 | $596.5M | $513.2M | ||
| Q1 24 | $566.7M | $598.8M |
净利润ICUIRRC
| Q4 25 | $-15.7M | $179.1M | ||
| Q3 25 | $-3.4M | $144.3M | ||
| Q2 25 | $35.3M | $237.6M | ||
| Q1 25 | $-15.5M | $97.1M | ||
| Q4 24 | $-23.8M | $94.8M | ||
| Q3 24 | $-33.0M | $50.7M | ||
| Q2 24 | $-21.4M | $28.7M | ||
| Q1 24 | $-39.5M | $92.1M |
毛利率ICUIRRC
| Q4 25 | 37.5% | 94.5% | ||
| Q3 25 | 37.4% | 92.5% | ||
| Q2 25 | 37.9% | 95.0% | ||
| Q1 25 | 34.7% | 93.1% | ||
| Q4 24 | 36.1% | 93.7% | ||
| Q3 24 | 34.8% | 94.3% | ||
| Q2 24 | 34.8% | 93.4% | ||
| Q1 24 | 32.7% | 94.7% |
营业利润率ICUIRRC
| Q4 25 | 1.0% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | -1.9% | — |
净利率ICUIRRC
| Q4 25 | -2.9% | 22.8% | ||
| Q3 25 | -0.6% | 22.0% | ||
| Q2 25 | 6.4% | 34.0% | ||
| Q1 25 | -2.6% | 11.5% | ||
| Q4 24 | -3.8% | 14.2% | ||
| Q3 24 | -5.6% | 8.9% | ||
| Q2 24 | -3.6% | 5.6% | ||
| Q1 24 | -7.0% | 15.4% |
每股收益（稀释后）ICUIRRC
| Q4 25 | $-0.63 | $0.75 | ||
| Q3 25 | $-0.14 | $0.60 | ||
| Q2 25 | $1.43 | $0.99 | ||
| Q1 25 | $-0.63 | $0.40 | ||
| Q4 24 | $-0.97 | $0.38 | ||
| Q3 24 | $-1.35 | $0.21 | ||
| Q2 24 | $-0.88 | $0.12 | ||
| Q1 24 | $-1.63 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $204.0K |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $2.1B | $4.3B |
| 总资产 | $4.1B | $7.4B |
| 负债/权益比越低杠杆越低 | — | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资ICUIRRC
| Q4 25 | — | $204.0K | ||
| Q3 25 | — | $175.0K | ||
| Q2 25 | — | $134.0K | ||
| Q1 25 | — | $344.6M | ||
| Q4 24 | $308.6M | $304.5M | ||
| Q3 24 | $312.5M | $277.4M | ||
| Q2 24 | $302.6M | $251.1M | ||
| Q1 24 | $251.4M | $343.1M |
总债务ICUIRRC
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
股东权益ICUIRRC
| Q4 25 | $2.1B | $4.3B | ||
| Q3 25 | $2.1B | $4.2B | ||
| Q2 25 | $2.1B | $4.1B | ||
| Q1 25 | $2.0B | $3.9B | ||
| Q4 24 | $2.0B | $3.9B | ||
| Q3 24 | $2.0B | $3.9B | ||
| Q2 24 | $2.0B | $3.9B | ||
| Q1 24 | $2.1B | $3.8B |
总资产ICUIRRC
| Q4 25 | $4.1B | $7.4B | ||
| Q3 25 | $4.1B | $7.2B | ||
| Q2 25 | $4.1B | $7.1B | ||
| Q1 25 | $4.2B | $7.4B | ||
| Q4 24 | $4.2B | $7.3B | ||
| Q3 24 | $4.3B | $7.2B | ||
| Q2 24 | $4.3B | $7.3B | ||
| Q1 24 | $4.3B | $7.4B |
负债/权益比ICUIRRC
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | — |
| 自由现金流率自由现金流/营收 | 6.6% | — |
| 资本支出强度资本支出/营收 | 4.6% | — |
| 现金转化率经营现金流/净利润 | — | 1.44× |
| 过去12个月自由现金流最近4个季度 | $91.8M | — |
8季度趋势，按日历期对齐
经营现金流ICUIRRC
| Q4 25 | $60.6M | $257.5M | ||
| Q3 25 | $56.7M | $247.5M | ||
| Q2 25 | $11.2M | $336.2M | ||
| Q1 25 | $51.3M | $330.1M | ||
| Q4 24 | $40.2M | $217.9M | ||
| Q3 24 | $36.1M | $245.9M | ||
| Q2 24 | $82.0M | $148.8M | ||
| Q1 24 | $45.8M | $331.9M |
自由现金流ICUIRRC
| Q4 25 | $36.0M | — | ||
| Q3 25 | $27.6M | — | ||
| Q2 25 | $-8.5M | — | ||
| Q1 25 | $36.7M | — | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $16.2M | — | ||
| Q2 24 | $62.5M | — | ||
| Q1 24 | $29.9M | — |
自由现金流率ICUIRRC
| Q4 25 | 6.6% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | -1.5% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 10.5% | — | ||
| Q1 24 | 5.3% | — |
资本支出强度ICUIRRC
| Q4 25 | 4.6% | — | ||
| Q3 25 | 5.4% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 2.8% | — |
现金转化率ICUIRRC
| Q4 25 | — | 1.44× | ||
| Q3 25 | — | 1.72× | ||
| Q2 25 | 0.32× | 1.42× | ||
| Q1 25 | — | 3.40× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 4.85× | ||
| Q2 24 | — | 5.18× | ||
| Q1 24 | — | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
